Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis

Studies have shown that the prevalence of RAS and BRAF mutations may differ by tumor sidedness among metastatic colorectal cancer (mCRC) patients. Both mutation status and tumor sidedness may impact survival and disease progression and RAS mutation status has been shown to predict response to anti‐e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bylsma, Lauren C., Gillezeau, Christina, Garawin, Tamer A., Kelsh, Michael A., Fryzek, Jon P., Sangaré, Laura, Lowe, Kimberly A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997095/
https://www.ncbi.nlm.nih.gov/pubmed/31856410
http://dx.doi.org/10.1002/cam4.2747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997095/
https://www.ncbi.nlm.nih.gov/pubmed/31856410
http://dx.doi.org/10.1002/cam4.2747

Ejemplares similares